Published date: 3 December 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
E14 4PU
Value of contract
£1
Procurement reference
CF-2733800D0O000000rwimUAA
Published date
3 December 2024
Closing date
18 July 2024
Closing time
12pm
Contract start date
26 November 2024
Contract end date
25 November 2025
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The supply of H5 influenza Vaccine
Value - The contract value is withheld from publication pursuant to regulation 50(6)(a) of the Public Contracts Regulations 2015 (as amended) as its release would be contrary to the public interest.
More information
Attachments
-
- 038942-2024.pdf
- 038942-2024
-
- H5 Contract Seqirus UK Ltd Redacted.pdf
- H5 Contract Seqirus UK Ltd Redacted
Award information
Awarded date
12 November 2024
Contract start date
26 November 2024
Contract end date
25 November 2025
Total value of contract
£1
This contract was awarded to 1 supplier.
SEQIRUS UK LIMITED
Address
Point 29 Market Street SL6 8AA
Reference
None
Supplier is SME?
No
About the buyer
Contact name
anna spencer
Address
10 South Colonnade
London
E14 4PU
United Kingdom
Share this notice
Closing: 18 July 2024, 12pm